Odyssey Health (ODYY) Liabilities and Shareholders Equity (2014 - 2026)
Odyssey Health (ODYY) reported Liabilities and Shareholders Equity of $373779.0 for Q2 2026, up 127.21% year-over-year from $164508.0 in Q2 2025, and down 48.18% sequentially from $721304.0 in Q1 2026.
Odyssey Health (ODYY) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
Odyssey Health has disclosed Liabilities and Shareholders Equity across 13 years of filings, most recently posting $373779.0 for Q2 2026.
- Quarterly Liabilities and Shareholders Equity rose 127.21% year-over-year to $373779.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.3 million (down 5.16% YoY) and the FY2025 annual result came in at $49723.0, down 91.52% from the prior year.
- Liabilities and Shareholders Equity slipped to $373779.0 in Q2 2026, from $721304.0 in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $14.0 million in Q1 2024 and bottomed at $49723.0 in Q3 2025.
- The 5-year median for Liabilities and Shareholders Equity is $459620.0 (2023), against an average of $1.9 million.
- Year-over-year, Liabilities and Shareholders Equity jumped 3014.39% in 2024 and plunged 98.79% in 2025.
- Odyssey Health's Liabilities and Shareholders Equity stood at $867723.0 in 2022, then slipped by 29.47% to $612039.0 in 2023, then slumped by 44.28% to $341045.0 in 2024, then tumbled by 57.89% to $143622.0 in 2025, then soared by 160.25% to $373779.0 in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $373779.0, $721304.0, and $143622.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Odyssey Health | - | - | - | 373,779.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 373,779.00 |
| Jan 31, 2026 | 721,304.00 |
| Oct 31, 2025 | 143,622.00 |
| Jul 31, 2025 | 49,723.00 |
| Apr 30, 2025 | 164,508.00 |
| Jan 31, 2025 | 266,866.00 |
| Oct 31, 2024 | 341,045.00 |
| Jul 31, 2024 | 586,146.00 |
| Apr 30, 2024 | 13.58 Mn |
| Jan 31, 2024 | 14.05 Mn |
| Oct 31, 2023 | 612,039.00 |
| Jul 31, 2023 | 455,793.00 |
| Apr 30, 2023 | 435,908.00 |
| Jan 31, 2023 | 463,447.00 |
| Oct 31, 2022 | 867,723.00 |
| Jul 31, 2022 | 569,677.00 |
| Apr 30, 2022 | 619,104.00 |
| Jan 31, 2022 | 334,215.00 |
| Oct 31, 2021 | 931,813.00 |
| Jul 31, 2021 | 610,533.00 |